Pediatric Infectious Diseases
FDA Approves Self-Injectable Formulation of Xolair
The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe persistent allergic asthma, nasal
Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. Pediatric research, however, has led to dramatic changes in child health. Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. In 1975, a childhood diagnosis of acute lymphocytic leukemia (ALL) often meant certain death within five years, and […]
The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe persistent allergic asthma, nasal
Copyright © 2024, A4M. All trademarks, registered or unregistered, are the property of their respective owners.